Eosinophilic Granulomatosis With Polyangiitis - 25 Studies Found
Recruiting |
: Rituximab in Eosinophilic Granulomatosis With Polyangiitis : Eosinophilic Granulomatosis With Polyangiitis (EGPA) : 2016-05-20 :
|
Recruiting |
: Determining Disease Activity Biomarkers in Individuals With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) :
|
Completed |
: A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis : Churg-Strauss Syndrome : 2013-12-19 :
|
Completed |
: Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome : Churg Strauss Syndrome : 2007-09-07 : Biological: Mepolizumab IV mepolizumab, 750 mg Other |
Terminated |
: Rituxan in Churg Strauss Syndrome With Renal Involvement : Churg-Strauss Syndrome : 2007-01-19 :
|
Terminated |
: CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors : Churg-Strauss Syndrome : 2006-11-13 :
|
Completed |
: Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome : Churg Strauss Syndrome : 2008-07-14 : Drug: mepolizumab 750 mg mepolizumab iv q4wk until week 32 |
Not yet recruiting |
: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome : Churg-Strauss Syndrome : 2016-03-14 : Biological: HPC cell infusion Administration of total lymp |
Not yet recruiting |
: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study : Asthma : 2016-10-17 : Drug: Reslizumab All subjects will receive Reslizumab |